# A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

> **NCT01511913** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 1411 (actual)

## Conditions studied

- Advanced Cutaneous Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01511913
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-03
- **Primary completion:** 2018-03-30
- **Final completion:** 2019-12-12
- **Target enrollment:** 1411 (ACTUAL)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511913, "A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01511913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*